Bio Techne (TECH) Inventory Turnover Ratio, from fourth quarter 2026 to fourth quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Bio techne Corp  (NASDAQ: TECH)
 

Bio Techne Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bio Techne's inventory turnover ratio, the ratio that measures Bio Techne's ability to manage its supply chain, sequentially decreased to 2.1 in the fourth quarter 2026, which does not come as a surprise, as the Bio Techne continue to experience headwinds, which also impact its supply chain. Bio Techne's average inventory processing period in the Jun 30 2026 quarter, has increased to 174 days, from 168 days, in the Mar 31 2026 quarter.

Within Healthcare sector 190 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2026, to 1511, from total ranking in the third quarter 2026 at 1632.

TECH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bio Techne Corp Market Share?

What is Inventory Turnover Ratio?




TECH Inventory Turnover Ratio (Jun 30 2026)
IV. Quarter
(Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Sep 30 2025)
I. Quarter
(Jun 30 2025)
IV. Quarter
Y / Y Inventory Growth 3.32 % 5.28 % 5.41 % 9.81 % 5.41 %
Y / Y Cost of Sales Growth -7.73 % 1.98 % 0.97 % -7.55 % 15.81 %
Inventory Turnover Ratio (TTM) 2.1 2.17 2.18 2.21 2.3
TECH's Total Ranking # 1511 # 1632 # 1531 # 1498 # 1524
Average inventory processing period 174 169 167 165 159
Seq. Inventory Growth -2.7 % 6.19 % -6.76 % 7.25 % -0.86 %
Seq. Cost of Sales Growth 6.6 % -0.96 % 6.12 % -17.65 % 17.82 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 191
Overall Market # 1511

Inventory Turnover Ratio Statistics
High Average Low
3.24 2.61 2.04
(Dec 31 2017)   (Dec 31 2012)




Financial Statements
Bio Techne's Inventories $ 196 Millions Visit TECH's Balance sheet
Bio Techne's Cost of Revenues TTM $ 415 Millions Visit TECH's Income Statement
What are TECH's Sales? Visit TECH's Sales by Segment

Other Inventory Turnover Ratios
Bio Techne's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TECH's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TECH's Competitors
Inventory Turnover Ratio for TECH's Suppliers
Inventory Turnover Ratio for TECH's Customers

You may also want to know
TECH's Sales Growth Rates TECH's Pe Price to earnings ratio TECH's Receivables Turnover Ratio TECH's Stock Quote
TECH's Net Income Growth Rates TECH's Ps Price to Sales ratio TECH's Sales per Employee TECH's Asset Turnover Ratio
TECH's Net Margin TECH's Pb Price to Book ratio TECH's Financial Strength Ratios TECH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions

Date modified: 2026-08-29T04:46:53+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.